Roche fights protectionist law

Swiss pharmaceutical company Roche's hostile $3bn offer for an American healthcare company has hit a major snag in the form of a local law as concerns rise about US markets becoming inhospitable to foreigners.

Last month Roche bid $3bn for Tuscon, Arizona-based Ventana Medical, a maker of cancer diagnostic systems, in a deal that would be a 55% premium to the target's three-month average stock price.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump